医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
5-硝基二氢吲哚 | 5-nitro-2,3-dihydro-1H-indole | 32692-19-6 | C8H8N2O2 |
|
5-硝基-Α-四氢萘酮 | 5-nitro-1-tetralone | 51114-73-9 | C10H9NO3 |
|
5-硝基-8-羟基喹啉 | nitroxoline | 4008-48-4 | C9H6N2O3 |
|
5-硝基-6-甲基-脲嘧啶 | 5-nitro-6-methyluracil | 16632-21-6 | C5H5N3O4 |
|
5-硝基-6-氯烟酸 | 6-chloro-5-nitronicotinic acid | 7477-10-3 | C6H3ClN2O4 |
|
5-硝基-6-氯嘧啶-2,4(1H,3H)-二酮 | 6-chloro-5-nitrouracil | 6630-30-4 | C4H2ClN3O4 |
|
5-硝基-4,6-二羟基嘧啶 | 4,6-dihydroxy-5-nitropyrimidine | 2164-83-2 | C4H3N3O4 |
|
5-硝基-4,6-二氨基嘧啶 | 4,6-Diamino-5-nitropyrimidine | 2164-84-3 | C4H5N5O2 |
|
5-硝基-3-氯吡啶 | 3-chloro-5-nitropyridine | 22353-33-9 | C5H3ClN2O2 |
|
5-硝基-2H-1,4-苯并恶嗪-3(4H)-酮 | 3,4-dihydro-5-nitro-2H-1,4-benzoxazin-3-one | 132522-81-7 | C8H6N2O4 |
|
5-硝基-2-茚酮 | 5-nitro-2-indanone | 116530-60-0 | C9H7NO3 |
|
5-硝基-2-苯基吲哚 | 5-nitro-2-phenyl-1H-indole | 4993-87-7 | C14H10N2O2 |
|
5-硝基-2-羟基吡啶-3-羧酸 | 2-hydroxy-5-nitronicotinic acid | 6854-07-5 | C6H4N2O5 |
|
5-硝基-2-羟基-3-氯吡啶 | 3-chloro-2-hydroxy-5-nitropyridine | 22353-38-4 | C5H3ClN2O3 |
|
5-硝基-2-甲氧基吡啶 | 2-methoxy-5-nitropyridine | 5446-92-4 | C6H6N2O3 |
|
5-硝基-2-氯吡啶-3-羧酸 | ethyl 2-chloro-5-nitro-3-pyridinecarboxylate | 151322-83-7 | C8H7ClN2O4 |
|
5-硝基-2-吡啶羧酸 | 5-nitropicolinic acid | 30651-24-2 | C6H4N2O4 |
|
5-硝基-2-吡啶乙酸甲酯 | methyl 2-(5-nitropyridin-2-yl)acetate | 292600-22-7 | C8H8N2O4 |
|
5-硝基-2-吡啶-3-基-1,3-苯并恶唑 | Benzoxazole, 5-nitro-2-(3-pyridinyl)- | 61382-20-5 | C12H7N3O3 |
|
5-硝基-2,3-二氯吡啶 | 2,3-dichloro-5-nitropyridine | 22353-40-8 | C5H2Cl2N2O2 |
|
5-硝基-2,3,3-三甲基吲哚 | 2,3,3-trimethyl-5-nitro-3H-indole | 3484-22-8 | C11H12N2O2 |
|
5-硝基-1H-吲唑-6-醇 | 5-nitro-1H-indazol-6-ol | 1082041-56-2 | C7H5N3O3 |
|
5-硝基-1H-吲哚-3-羧酸甲酯 | methyl 5-nitro-1H-indole-3-carboxylate | 686747-51-3 | C10H8N2O4 |
|
5-硝基-1H-吲哚-1-甲酸叔丁酯 | tert-butyl 5-nitro-1H-indole-1-carboxylate | 166104-19-4 | C13H14N2O4 |
|
5-硝基-1-(苯基甲基)-1H-咪唑-4-羧酸 | 5-nitro-1-(phenylmethyl)-1H-imidazole-4-carboxylic acid | 69195-96-6 | C11H9N3O4 |
|
5-硝基-1,3-二氢-2H-吲哚-2-酮 | 5-nitrooxindole | 20870-79-5 | C8H6N2O3 |
|
5-甲酰基吡啶甲酸甲酯 | methyl 5-formylpicolinate | 55876-91-0 | C8H7NO3 |
|
5-甲酰基吡啶-3-硼酸酯 | 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinaldehyde | 848093-29-8 | C12H16BNO3 |
|
5-甲酰基吡啶-2-甲腈 | 5-formylpicolinonitrile | 131747-68-7 | C7H4N2O |
|
5-甲酰基-2-甲氧基-4-甲基吡啶 | 6-methoxy-4-methylnicotinaldehyde | 123506-66-1 | C8H9NO2 |
|
5-甲酰基-2-甲基苯甲腈 | 5-formyl-2-methylbenzonitrile | 27613-36-1 | C9H7NO |
|
5-甲酰基-2-甲基吡啶 | 2-methyl-5-formylpyridine | 53014-84-9 | C7H7NO |
|
5-甲苯磺酰基-5H-吡咯并[2,3-B]吡嗪-2-胺基甲酸叔丁酯 | tert-butyl (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)carbamate | 1201187-44-1 | C18H20N4O4S |
|
5-甲氨基尿嘧啶 | 5-(methylamino)pyrimidine-2,4(1H,3H)-dione | 7577-92-6 | C5H7N3O2 |
|
5-甲氨基嘧啶 | N-methylpyrimidin-5-amine | 40492-24-8 | C5H7N3 |
|
5-甲氧基苯并噻吩 | 5-methoxybenzothiophene | 20532-30-3 | C9H8OS |
|
5-甲氧基色胺盐酸盐 | 5-methoxytryptamine hydrochloride | 17107-33-4 | C11H14N2O*ClH |
|
5-甲氧基胞苷 | 5-methoxycytidine | 37805-90-6 | C10H15N3O6 |
|
5-甲氧基烟酸 | 5-methoxynicotinic acid | 20826-03-3 | C7H7NO3 |
|
5-甲氧基烟腈 | 5-methoxynicotinonitrile | 298204-74-7 | C7H6N2O |
|
5-甲氧基异喹啉盐酸盐 | 5-Methoxyisoquinoline hydrochloride | 1418117-87-9 | C10H10ClNO |
|
5-甲氧基异喹啉-1(2H)-酮 | 5-methoxyisoquinolin-1-ol | 118313-35-2 | C10H9NO2 |
|
5-甲氧基异喹啉 | 5-methoxyisoquinoline | 90806-58-9 | C10H9NO |
|
5-甲氧基嘧啶-2-甲腈 | 5-methoxypyrimidine-2-carbonitrile | 87362-32-1 | C6H5N3O |
|
5-甲氧基嘧啶-2(1H)-酮 | 2-Hydroxy-5-methoxypyrimidin | 16290-93-0 | C5H6N2O2 |
|
5-甲氧基嘧啶 | 5-methoxypyrimidine | 31458-33-0 | C5H6N2O |
|
5-甲氧基喹啉-8-胺 | 5-methoxyquinolin-8-amine | 30465-68-0 | C10H10N2O |
|
5-甲氧基喹啉-6-胺 | 5-Methoxy-quinolin-6-ylamine | 54620-48-3 | C10H10N2O |
|
5-甲氧基喹啉-2(1H)-酮 | 5-methoxyquinolin-2(1H)-one | 160893-04-9 | C10H9NO2 |
|
5-甲氧基喹啉 | 5-methoxyquinoline | 6931-19-7 | C10H9NO |
|